Without those acquisitions, revenue would be declining this year, David Price, the company's chief financial officer, said in an interview Cornerstone's oldest products face competition from cheaper generics that are cutting into sales "We have transitioned the business," Collard said in an interview Ladenburg Thalmann analyst Matthew Kaplan reiterated his "buy" rating for Cornerstone in the wake of the company's guidance, even though he lowered his 2010 revenue and net income projections "We continue to be impressed with the company's transformation from a small, private company to a larger, pulic company with multiple marketing products and internal pipeline candidates with strong revenue potential," Kaplan wrote 
Share:  Without those acquisitions, revenue would be declining this year, David Price, the company's chief financial officer, said in an interview <span class="company">Cornerstone</span>'s oldest products face competition from cheaper generics that are cutting into sales "We have transitioned the business," Collard said in an interview<span class="sent"> Ladenburg Thalmann analyst <span class="analyst">Matthew Kaplan</span> reiterated his "buy" rating for <span class="company">Cornerstone</span> in the wake of the company's guidance, even though he lowered his 2010 revenue and net income projections</span> "We continue to be impressed with the company's transformation from a small, private company to a larger, pulic company with multiple marketing products and internal pipeline candidates with strong revenue potential," Kaplan wrote...Without those acquisitions, revenue would be declining this year, David Price, the company's chief financial officer, said in an interview <span class="company">Cornerstone</span>'s oldest products face competition from cheaper generics that are cutting into sales "We have transitioned the business," Collard said in an interview<span class="sent"> Ladenburg Thalmann analyst <span class="analyst">Matthew Kaplan</span> reiterated his "buy" rating for <span class="company">Cornerstone</span> in the wake of the company's guidance, even though he lowered his 2010 revenue and net income projections</span> "We continue to be impressed with the company's transformation from a small Tweet this 

"This is an important validation of the Teva partnership, which is the primary driver of our valuation and excitement about Antares stock," Ladenburg Thalmann analyst Matthew Kaplan said by phone. Shares of Antares rose as much as 58 percent to a new year high of $1.14, before paring some gains to trade up at $1.02 in morning trade Monday on the American Stock Exchange. 
Share:  <span class="sent">"This is an important validation of the Teva partnership, which is the primary driver of our valuation and excitement about <span class="company">Antares</span> stock," Ladenburg Thalmann analyst <span class="analyst">Matthew Kaplan</span> said by phone. </span> Shares of <span class="company">Antares</span> rose as much as 58 percent to a new year high of $1.14, before paring some gains to trade up at $1.02 in morning trade Monday on the American Stock Exchange. ...<span class="sent">"This is an important validation of the Teva partnership, which is the primary driver of our valuation and excitement about <span class="company">Antares</span> stock," Ladenburg Thalmann analyst <span class="analyst">Matthew Kaplan</span> said by phone. </span> Shares of <span class="company">Antares</span> rose as much as 58 percent to a new year high of $1.14, before paring some gains to trade up at $1.02 in morning trade Monday on the American Stock Exchange. Tweet this 

"This is an important validation of the Teva partnership, which is the primary driver of our valuation and excitement about Antares stock," Ladenburg Thalmann analyst Matthew Kaplan said by phone. Shares of Antares rose as much as 58 percent to a new year high of $1.14, before paring some gains to trade up at $1.02 in morning trade Monday on the American Stock Exchange. 
Share:  <span class="sent">"This is an important validation of the <span class="company">Teva</span> partnership, which is the primary driver of our valuation and excitement about Antares stock," Ladenburg Thalmann analyst <span class="analyst">Matthew Kaplan</span> said by phone. </span> Shares of Antares rose as much as 58 percent to a new year high of $1.14, before paring some gains to trade up at $1.02 in morning trade Monday on the American Stock Exchange. ...<span class="sent">"This is an important validation of the <span class="company">Teva</span> partnership, which is the primary driver of our valuation and excitement about Antares stock," Ladenburg Thalmann analyst <span class="analyst">Matthew Kaplan</span> said by phone. </span> Shares of Antares rose as much as 58 percent to a new year high of $1.14, before paring some gains to trade up at $1.02 in morning trade Monday on the American Stock Exchange. Tweet this